vs
Kearny Financial Corp.（KRNY）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Kearny Financial Corp.的1.6倍（$69.8M vs $44.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 22.9%，领先361.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 14.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 9.3%）
Kearny Financial Corp是美国的银行控股企业，运营面向社区的Kearny Bank金融机构，主要服务新泽西州及纽约大都会区客户，提供涵盖存款账户、按揭贷款、商业信贷、财富管理在内的个人及商业金融服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
KRNY vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.6倍
$44.3M
营收增速更快
RIGL
高出6.4%
14.8%
净利率更高
RIGL
高出361.2%
22.9%
两年增速更快
RIGL
近两年复合增速
9.3%
损益表 — Q1 FY2027 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.3M | $69.8M |
| 净利润 | $10.1M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 22.9% | 384.0% |
| 营收同比 | 14.8% | 21.2% |
| 净利润同比 | 7.3% | 1769.2% |
| 每股收益（稀释后） | $0.16 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRNYRIGL
| Q1 27 | $44.3M | — | ||
| Q1 26 | $44.3M | — | ||
| Q4 25 | $43.5M | $69.8M | ||
| Q3 25 | $43.6M | $69.5M | ||
| Q2 25 | $40.8M | $101.7M | ||
| Q1 25 | $38.6M | $53.3M | ||
| Q4 24 | $37.5M | $57.6M | ||
| Q3 24 | $37.1M | $55.3M |
净利润KRNYRIGL
| Q1 27 | $10.1M | — | ||
| Q1 26 | $10.1M | — | ||
| Q4 25 | $9.4M | $268.1M | ||
| Q3 25 | $9.5M | $27.9M | ||
| Q2 25 | $6.8M | $59.6M | ||
| Q1 25 | $6.6M | $11.4M | ||
| Q4 24 | $6.6M | $14.3M | ||
| Q3 24 | $6.1M | $12.4M |
毛利率KRNYRIGL
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% |
营业利润率KRNYRIGL
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 27.1% | 33.2% | ||
| Q3 25 | 27.5% | 40.9% | ||
| Q2 25 | 20.0% | 60.1% | ||
| Q1 25 | 20.3% | 23.9% | ||
| Q4 24 | 20.9% | 28.9% | ||
| Q3 24 | 19.4% | 25.4% |
净利率KRNYRIGL
| Q1 27 | 22.9% | — | ||
| Q1 26 | 22.9% | — | ||
| Q4 25 | 21.7% | 384.0% | ||
| Q3 25 | 21.8% | 40.2% | ||
| Q2 25 | 16.6% | 58.6% | ||
| Q1 25 | 17.2% | 21.5% | ||
| Q4 24 | 17.5% | 24.9% | ||
| Q3 24 | 16.4% | 22.5% |
每股收益（稀释后）KRNYRIGL
| Q1 27 | $0.16 | — | ||
| Q1 26 | $0.16 | — | ||
| Q4 25 | $0.15 | $14.11 | ||
| Q3 25 | $0.15 | $1.46 | ||
| Q2 25 | $0.11 | $3.28 | ||
| Q1 25 | $0.11 | $0.63 | ||
| Q4 24 | $0.10 | $0.82 | ||
| Q3 24 | $0.10 | $0.70 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $123.8M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $763.0M | $391.5M |
| 总资产 | $7.6B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资KRNYRIGL
| Q1 27 | $123.8M | — | ||
| Q1 26 | $123.8M | — | ||
| Q4 25 | $147.3M | $155.0M | ||
| Q3 25 | $130.1M | $137.1M | ||
| Q2 25 | $167.3M | $108.4M | ||
| Q1 25 | $126.1M | $77.1M | ||
| Q4 24 | $141.6M | $77.3M | ||
| Q3 24 | $155.6M | $61.1M |
总债务KRNYRIGL
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M |
股东权益KRNYRIGL
| Q1 27 | $763.0M | — | ||
| Q1 26 | $763.0M | — | ||
| Q4 25 | $757.4M | $391.5M | ||
| Q3 25 | $753.2M | $117.6M | ||
| Q2 25 | $746.0M | $81.9M | ||
| Q1 25 | $748.1M | $18.6M | ||
| Q4 24 | $744.9M | $3.3M | ||
| Q3 24 | $751.5M | $-14.6M |
总资产KRNYRIGL
| Q1 27 | $7.6B | — | ||
| Q1 26 | $7.6B | — | ||
| Q4 25 | $7.6B | $513.6M | ||
| Q3 25 | $7.6B | $242.5M | ||
| Q2 25 | $7.7B | $206.7M | ||
| Q1 25 | $7.7B | $176.0M | ||
| Q4 24 | $7.7B | $164.0M | ||
| Q3 24 | $7.8B | $139.4M |
负债/权益比KRNYRIGL
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流KRNYRIGL
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $14.3M | $22.0M | ||
| Q3 25 | $1.5M | $24.0M | ||
| Q2 25 | $24.8M | $30.5M | ||
| Q1 25 | $16.8M | $-893.0K | ||
| Q4 24 | $-2.7M | $14.5M | ||
| Q3 24 | $2.5M | $21.7M |
自由现金流KRNYRIGL
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $21.4M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — |
自由现金流率KRNYRIGL
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 52.4% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — |
资本支出强度KRNYRIGL
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 8.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — |
现金转化率KRNYRIGL
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.51× | 0.08× | ||
| Q3 25 | 0.16× | 0.86× | ||
| Q2 25 | 3.66× | 0.51× | ||
| Q1 25 | 2.53× | -0.08× | ||
| Q4 24 | -0.40× | 1.01× | ||
| Q3 24 | 0.42× | 1.75× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
